Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Beam Therapeutics Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $92.2 Billion
- Q3 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 10,608 shares of BEAM stock, worth $284,824. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,608
Previous 11,610
8.63%
Holding current value
$284,824
Previous $272,000
4.78%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BEAM
# of Institutions
242Shares Held
76.7MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$220 Million1.01% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$205 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.62MShares$205 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$190 Million1.53% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$130 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.89B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...